Chairman, Radiation Oncology at Cedars-Sinai Medical Center
Radiation Oncology
Dr. Howard M. Sandler, MD
Howard Sandler is an expert in the field of Radiation Oncology. He researched medicine at University of Connecticut School of Medicine. University of Connecticut School of Medicine is ranked 60 in research and 49 in primary care medicine He received 8 awards: "The American Society of Radiation Oncology (FASTRO)", "Named in Best Doctors in America", "Teacher-of-the-Year in the Department of Radiation Oncology", "1996Named in Best Doctors in America: Midwest Region", "ESTRO Travel Grant", "American Cancer Society Clinical Oncology Fellow", "University of Connecticut Alumni Scholar" and "Phi Beta Kappa". Doctor Howard M. Sandler, MD is a published physician as well. He has 36 publications published. The latest was: Cardiovascular Mortality Following Short-term Androgen Deprivation in Clinically Localized Prostate Cancer: An Analysis of RTOG 94-08. He accepts Medicare.
Publications
- Cardiovascular Mortality Following Short-term Androgen Deprivation in Clinically Localized Prostate Cancer: An Analysis of RTOG 94-08.
- Re: Radiation for Prostate Cancer: Intensity Modulated Radiation Therapy versus Proton Beam: B. S. Hoppe, C. Bryant and H. M. Sandler J Urol 2015;193:1089-1091.
- Active surveillance for prostate Cancer: the role of the pathologist.
- Radiation for Prostate Cancer: Intensity Modulated Radiation Therapy versus Proton Beam.
- Adjuvant and salvage radiotherapy after Prostatectomy: american society of clinical oncology clinical practice guideline endorsement.
- Impact of biochemical failure classification on clinical outcome: A secondary analysis of Radiation Therapy Oncology Group 9202 and 9413.
- A TISSUE BIOMARKER BASED MODEL THAT IDENTIFIES PATIENTS WITH A HIGH RISK OF DISTANT METASTASIS AND DIFFERENTIAL SURVIVAL BY LENGTH OF ANDROGEN DEPRIVATION THERAPY IN R...
- Stereotactic body radiation therapy: Let's not give up on progress.
- The critical role of the pathologist in determining eligibility for active surveillance as a management option in patients with prostate Cancer: consensus statement wi...
- Recommended patient-reported core set of symptoms to measure in prostate Cancer treatment trials.
- Complications of prostate Cancer treatment.
- Dose to the inferior rectum is strongly associated with patient reported bowel quality of life after radiation therapy for prostate Cancer.
- Neoadjuvant androgen deprivation therapy leads to immediate impairment of vitality/hormonal and sexual quality of life: results of a multicenter prospective study.
- Satisfaction with Information Used to Choose Prostate Cancer Treatment.
- Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the radiation therapy o...
- Comparative effectiveness study of patient-reported outcomes after proton therapy or intensity-modulated radiotherapy for prostate Cancer.
- Larger maximum tumor diameter at radical prostatectomy is associated with increased biochemical failure, metastasis, and death from prostate Cancer after salvage radia...
- Multi-institutional Prospective Evaluation of Bowel Quality of Life After Prostate External Beam Radiation Therapy Identifies Patient and Treatment Factors Associated ...
- Retrospective evaluation reveals that long-term androgen deprivation therapy improves cause-specific and overall survival in the setting of dose-escalated radiation fo...
- Patient-reported outcomes after 3-dimensional conformal, intensity-modulated, or proton beam radiotherapy for localized prostate Cancer.
- The addition of low-dose-rate brachytherapy and androgen-deprivation therapy decreases biochemical failure and prostate Cancer death compared with dose-escalated exter...
- The dosimetric impact of Prostate rotations during electromagnetically guided external-beam radiation therapy.
- Variation in the definition of clinical target volumes for pelvic nodal conformal radiation therapy for prostate Cancer.
- Phase III multi-institutional trial of adjuvant chemotherapy with paclitaxel, estramustine, and oral etoposide combined with long-term androgen suppression therapy and...
- Prognostic value of survivin in locally advanced prostate Cancer: study based on RTOG 8610.
- Evaluating the relationships between rectal normal tissue complication probability and the portion of seminal vesicles included in the clinical target volume in intens...
- No effect of statins on biochemical outcomes after radiotherapy for localized prostate Cancer.
- Cardiovascular mortality after androgen deprivation therapy for locally advanced prostate Cancer: RTOG 85-31.
- A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate Cancer.
- Predicting biochemical failure and overall survival through intratherapy PSA changes during definitive external beam radiotherapy.
- Determinants of change in prostate-specific antigen over time and its association with recurrence after external beam radiation therapy for prostate Cancer in five lar...
- Dosimetric analysis of radiation therapy oncology group 0321: The importance of urethral dose.
- Can electronic web-based technology improve quality of life data collection? Analysis of Radiation Therapy Oncology Group 0828.
- Patterns of practice in radiation therapy for non-small cell lung Cancer among members of the American Society for Radiation Oncology.
- US Food and Drug Administration medical device review and approval; Myths, misconceptions, realities, and potential policy changes.
Schools
University Of Connecticut School Of Medicine
St Francis Hospital
Hospital Of The University Of Pennsylvania
University Of Connecticut
Procedures Preformed
- Image-Guided Radiation Therapy (IGRT)
- Intensity-Modulated Radiation Therapy (IMRT)
- Stereotactic Body Radiotherapy (SBRT)
Conditions Treated
- Bladder Cancer
- Prostate Cancer
- Skin Cancer
- Testicular Cancer
Doctors Specialties
Accepted Insurances
Awards
- The American Society of Radiation Oncology (FASTRO)
- Named in “Best Doctors in Americaâ€Â
- Teacher-of-the-Year in the Department of Radiation Oncology
- 1996 Named in “Best Doctors in America: Midwest Region
- ESTRO Travel Grant
- American Cancer Society Clinical Oncology Fellow
- University of Connecticut Alumni Scholar
- Phi Beta Kappa
Education
-
University of Connecticut
-
University of Pennsylvania Health System
-
University of Connecticut School of Medicine
Hospital
-
Cedars-Sinai Medical Center
Drug Facts
| NPI NUMBER |
|
1508959800 |
| NPPES Provider LastName |
|
SANDLER |
| NPPES Provider FirstName |
|
HOWARD |
| NPPES Provider ZIPCode |
|
900481804 |
| NPPES Provider State |
|
CA |
| Specialty Description |
|
Radiation Oncology |
| Total Claim Count |
|
24.0 |
| Distinct Opioid Count |
|
0.0 |
| Opioid Claim Count |
|
0.0 |
| Percent Opioid Claims |
|
0.0 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
| National Provider Identifier [NPI] |
1508959800 |
| Last Name Of The Provider |
SANDLER |
| First Name Of The Provider |
HOWARD |
| View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog
This Doctor is OpenDoctor Recommended.